OrbiMed Capital GP V LLC

USReporting entityDirector

Transactions

Issuers

Buys / Sells

14/21

Last tx

23 Oct 2025

FrançaisSign in Try free 14d

Insider

OrbiMed Capital GP V LLC

USReporting entityDirector

Transactions

Issuers

Buys / Sells

14/21

Last tx

23 Oct 2025

Behaviour

4 purchases reported after at least 12 months of silence — most recent on 06 May 2024.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Compass Therapeutics, Inc.	14,625,478	reported	10 May 2022	tx 3+125,359
Tricida, Inc.	10,280,947	reported	15 Nov 2021	tx 12+12,447,614−41,873,036
PMV Pharmaceuticals, Inc.	4,975,291	reported	23 Oct 2025	tx 2−1,026,253
Adaptimmune Therapeutics PLC	4,901,310	reported	06 Jun 2018	tx 5−200,000
RHYTHM PHARMACEUTICALS, INC.

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.

1 month

+53.7%

Sample5

Win rate (≥5%)100%

Hit rate (>0)100%

3 months

+62.7%

Sample5

Win rate (≥5%)100%

Hit rate (>0)100%

6 months

+32.5%

Sample5

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
23 Oct 2025	SALE	PMV Pharmaceuticals, Inc.	1,000,000	1.52 USD
06 May 2024	PURCHASE	Corvus Pharmaceuticals, Inc.	1,397,684	—	derivfirst after silence
06 May 2024	PURCHASE	Corvus Pharmaceuticals, Inc.	1,444,085	1.73 USD	deriv
26 May 2022	SALE	PMV Pharmaceuticals, Inc.	26,253	15.93 USD
06 May 2022	PURCHASE	Compass Therapeutics, Inc.	10,200	1.63 USD	first after silence
09 May 2022	PURCHASE	Compass Therapeutics, Inc.	90,712	1.56 USD
10 May 2022	PURCHASE	Compass Therapeutics, Inc.	24,447	1.60 USD
15 Nov 2021	GRANT_AWARD	Tricida, Inc.	666,667	6.00 USD
15 Nov 2021	GRANT_AWARD	Tricida, Inc.	666,667	—	deriv
20 Sept 2021	SALE	Corvus Pharmaceuticals, Inc.	1,109,644	6.09 USD
08 Dec 2020	EXERCISE	Whitehawk Therapeutics, Inc.	21,400	0.96 USD
08 Dec 2020	SALE	Whitehawk Therapeutics, Inc.	21,400	1.96 USD
08 Dec 2020	EXERCISE	Whitehawk Therapeutics, Inc.	21,400	0.00 USD	deriv
17 Aug 2020	SALE	Inspire Medical Systems, Inc.	94,900	107.49 USD
18 Aug 2020	SALE	Inspire Medical Systems, Inc.	43,543	108.54 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	75,000	83.21 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	25,000	84.55 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	400,000	84.42 USD
06 Aug 2019	PURCHASE	Corvus Pharmaceuticals, Inc.	142,656	3.51 USD
03 Apr 2019	PURCHASE	Tricida, Inc.	225,000	36.00 USD
11 Dec 2018	SALE	Inspire Medical Systems, Inc.	614,772	37.60 USD
02 Jul 2018	CONVERSION	Tricida, Inc.	4,300,774	—
02 Jul 2018	CONVERSION	Tricida, Inc.	1,559,716	—
02 Jul 2018	CONVERSION	Tricida, Inc.	3,591,194	—
02 Jul 2018	CONVERSION	Tricida, Inc.	1,069,175	—

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Compass Therapeutics, Inc.	14,625,478	reported	10 May 2022	tx 3+125,359
Tricida, Inc.	10,280,947	reported	15 Nov 2021	tx 12+12,447,614−41,873,036
PMV Pharmaceuticals, Inc.	4,975,291	reported	23 Oct 2025	tx 2−1,026,253
Adaptimmune Therapeutics PLC	4,901,310	reported	06 Jun 2018	tx 5−200,000
RHYTHM PHARMACEUTICALS, INC.

Track record

Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.

1 month

+53.7%

Sample5

Win rate (≥5%)100%

Hit rate (>0)100%

3 months

+62.7%

Sample5

Win rate (≥5%)100%

Hit rate (>0)100%

6 months

+32.5%

Sample5

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
23 Oct 2025	SALE	PMV Pharmaceuticals, Inc.	1,000,000	1.52 USD
06 May 2024	PURCHASE	Corvus Pharmaceuticals, Inc.	1,397,684	—	derivfirst after silence
06 May 2024	PURCHASE	Corvus Pharmaceuticals, Inc.	1,444,085	1.73 USD	deriv
26 May 2022	SALE	PMV Pharmaceuticals, Inc.	26,253	15.93 USD
06 May 2022	PURCHASE	Compass Therapeutics, Inc.	10,200	1.63 USD	first after silence
09 May 2022	PURCHASE	Compass Therapeutics, Inc.	90,712	1.56 USD
10 May 2022	PURCHASE	Compass Therapeutics, Inc.	24,447	1.60 USD
15 Nov 2021	GRANT_AWARD	Tricida, Inc.	666,667	6.00 USD
15 Nov 2021	GRANT_AWARD	Tricida, Inc.	666,667	—	deriv
20 Sept 2021	SALE	Corvus Pharmaceuticals, Inc.	1,109,644	6.09 USD
08 Dec 2020	EXERCISE	Whitehawk Therapeutics, Inc.	21,400	0.96 USD
08 Dec 2020	SALE	Whitehawk Therapeutics, Inc.	21,400	1.96 USD
08 Dec 2020	EXERCISE	Whitehawk Therapeutics, Inc.	21,400	0.00 USD	deriv
17 Aug 2020	SALE	Inspire Medical Systems, Inc.	94,900	107.49 USD
18 Aug 2020	SALE	Inspire Medical Systems, Inc.	43,543	108.54 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	75,000	83.21 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	25,000	84.55 USD
03 Mar 2020	SALE	Inspire Medical Systems, Inc.	400,000	84.42 USD
06 Aug 2019	PURCHASE	Corvus Pharmaceuticals, Inc.	142,656	3.51 USD
03 Apr 2019	PURCHASE	Tricida, Inc.	225,000	36.00 USD
11 Dec 2018	SALE	Inspire Medical Systems, Inc.	614,772	37.60 USD
02 Jul 2018	CONVERSION	Tricida, Inc.	4,300,774	—
02 Jul 2018	CONVERSION	Tricida, Inc.	1,559,716	—
02 Jul 2018	CONVERSION	Tricida, Inc.	3,591,194	—
02 Jul 2018	CONVERSION	Tricida, Inc.	1,069,175	—